Coeptis Therapeutics Holdings, Inc.
Company Information
Industry
Finance Services
SIC Code
6199
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
105 BRADFORD ROAD, SUITE 420, WEXFORD, PA, 15090
Mailing Address
105 BRADFORD ROAD, SUITE 420, WEXFORD, PA, 15090
Phone
724-934-6467
Fiscal Year End
1231
EIN
981465952
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Strategic expansion into NexGenAI Solutions Group Inc. for immediate income and diversification beyond biotech's long development cycles.
- Securing funding through convertible notes and a Standby Equity Purchase Agreement (SEPA) to support operations and development.
Material Events
8-K
Strategy Change
February 4, 2026
High Impact
- Merger with Z Squared Technologies creates a diversified healthcare technology leader focused on AI-driven analytics and digital therapeutics.
- Retains promising GEAR Therapeutics CAR T-cell therapy platform, signaling a strategic focus on high-potential, cutting-edge therapies.
8-K
Legal Issue
January 16, 2026
High Impact
- Coeptis Therapeutics received a warning letter from Nasdaq for non-compliance, specifically for failing to hold its annual shareholder meeting within the required timeframe.
- The company's fiscal year ended on December 31, 2024, and the annual meeting was not held by the deadline.
Related Companies
Companies in the same industry (SIC: 6199)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.